| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.6 |